|
|
|
|
|||||
| Accession | Disease | Description | Year | Source | RNA-Seq | Count | Biomarkers |
| GSE45498 | Breast Cancer | Integrated microRNA and mRNA Signatures Associated with Survival in Triple Negative Breast Cancer II | 2013 | Tissue | Y | 536 |
|
| GSE81000 | Breast Cancer | Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome | 2016 | Serum | N | 425 |
|
| GSE58215 | Breast Cancer | Integrated analysis reveals microRNA networks coordinately expressed with key proteins in breast cancer | 2014 | Tissue | N | 289 |
|
| GSE58210 | Breast Cancer | Integrated analysis reveals microRNA networks coordinately expressed with key proteins in breast cancer [miRNA] | 2014 | Tissue | N | 283 |
|
| GSE54470 | Breast Cancer | Downregulation of micro RNAs 145-3p and 145-5p is a Long-Term Predictor of Postmenopausal Breast Cancer Risk: the ORDET prospective study | 2014 | Tissue | N | 266 |
|
| GSE22220 | Breast Cancer | Analysis of early primary breast cancer to identify prognostic markers and associated pathways: mRNA and miRNA profiling | 2011 | Tissue | N | 216 |
|
| GSE131599 | Breast Cancer | Refinement of breast cancer molecular classification by miRNA expression profiles | 2019 | Tissue | Y | 191 |
|
| GSE31309 | Breast Cancer | miRNA expression profiling in early stage breast cancer | 2011 | Blood | N | 185 |
|
| GSE59595 | Breast Cancer | Gene and microRNA expression profiling of breast tumors from Chinese and Italian women | 2014 | Tissue | N | 175 |
|
| GSE28884 | Breast Cancer | MicroRNA sequence and expression analysis in breast tumors by deep sequencing | 2011 | Tissue | Y | 161 |
|
| GSE28884 | Breast Cancer | MicroRNA sequence and expression analysis in breast tumors by deep sequencing | 2011 | Tissue | Y | 161 |
|
| GSE58606 | Breast Cancer | Tumor microRNA expression profiling identifies circulating microRNAs for earlier breast cancer detection | 2014 | Tissue | N | 133 |
|
| GSE59829 | Breast Cancer | Mir-30e* is an independent subtype-specific prognostic marker in breast cancer | 2014 | Tissue | N | 123 |
|
| GSE103161 | Breast Cancer | Primary breast tumour of patient without relapse (55) ; Primary breast tumour of patient with relapse (55) | 2018 | Tissue | N | 110 |
|
| GSE101841 | Breast Cancer | Serum microRNA profile of Her2 positive metastatic breast cancer patients | 2017 | Serum | N | 103 |
|
| GSE26659 | Breast Cancer | microRNA and cancer progression in breast tumors | 2011 | Tissue | N | 94 |
|
| GSE134108 | Breast Cancer | Brain metastasis-related microRNAs in patients with advanced breast cancer | 2019 | Blood | N | 79 |
|
| GSE70754 | Breast Cancer | The prognostic significance of the dynamic changes of miRNA expression in locally advanced BC during neo-adjuvant chemotherapy treatment | 2015 | Tissue | N | 63 |
|
| GSE97811 | Breast Cancer | Tissue microRNA signatures to predict breast cancer recurrence in young women aged under 35 years old | 2017 | Tissue | N | 61 |
|
| GSE42128 | Breast Cancer | Clinical Utility of Circulating MicroRNA Signatures for Breast Cancer Diagnosis | 2012 | Serum | N | 54 |
|
| GSE98181 | Breast Cancer | Circulating miRNA profiles from serum of women at high-risk for breast cancer | 2017 | Serum | N | 48 |
|
| GSE118782 | Breast Cancer | Small noncoding RNA levels in plasma from breast cancer patients and healthy controls | 2018 | Plasma | N | 40 |
|
| GSE38867 | Breast Cancer | MicroRNAs expression profiling during breast cancer progression | 2012 | Tissue | N | 28 |
|
| GSE158945 | Breast Cancer | Circulating tRNA-derived small RNAs (tsRNAs) signature for the diagnosis and prognosis of breast cancer | 2020 | Tissue | Y | 12 |
|